{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:10Z","timestamp":1787026570792,"version":"build-2736575974"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"\n While antiretroviral therapy (ART) has proven effective in suppressing viremia and disease progression among people living with human immunodeficiency virus (HIV; PLWH), suboptimal CD4\n +<\/jats:sup>\n T cell reconstitution remains a major obstacle in nearly 30% of ART-treated individuals. Epidemiological studies demonstrate that obesity, or a body mass index (BMI) \u2265 30 kg\/m\n 2<\/jats:sup>\n , is positively correlated with greater CD4\n +<\/jats:sup>\n T cell recovery in PLWH on ART. Leptin is a known immunomodulator that is produced in proportion to fat mass and is increased in obese individuals, including PLWH. We hypothesized that CD4\n +<\/jats:sup>\n T cells from obese PLWH have increased cell proliferation and cytokine production compared to cells from lean PLWH, potentially modulated by differential effects of leptin signaling. To test this hypothesis, peripheral blood mononuclear cells from obese and lean PLWH with long-term virologic suppression on the same ART regimen were pretreated with recombinant leptin and then stimulated with anti-CD3\/CD28 or PMA\/ionomycin to measure Ki67 expression, leptin receptor (LepR) surface expression and cytokine production. In the absence of leptin, Ki67 expression and IL-17A production were significantly higher in CD4\n +<\/jats:sup>\n T cells from obese compared to lean PLWH. However, LepR expression was significantly lower on CD4\n +<\/jats:sup>\n T cells from obese compared to lean PLWH. After leptin treatment, Ki67 expression was significantly increased in CD4\n +<\/jats:sup>\n T cells from obese PLWH compared to the lean participants. Leptin also increased IL-17A production in CD4\n +<\/jats:sup>\n T cells from obese healthy controls. In contrast, leptin decreased IL-17A production in CD4\n +<\/jats:sup>\n T cells from both obese and lean PLWH. Combined, these results demonstrate that obesity is associated with greater CD4\n +<\/jats:sup>\n T cell proliferation among PLWH, and that higher circulating leptin levels in obesity may contribute to improved CD4\n +<\/jats:sup>\n T reconstitution in PLWH initiating ART.\n <\/jats:p>","DOI":"10.3389\/fimmu.2021.796898","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T23:34:16Z","timestamp":1642376056000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Leptin Promotes Greater Ki67 Expression in CD4+ T Cells From Obese Compared to Lean Persons Living With HIV"],"prefix":"10.3389","volume":"12","author":[{"given":"Hubaida","family":"Fuseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy H.","family":"Nochowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaToya","family":"Hannah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine N.","family":"Wanjalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis L.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Bailin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa H.","family":"Hasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Koethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros A.","family":"Kalams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00395","article-title":"CD4 T-Cell Responses in Primary HIV Infection: Interrelationship With Immune Activation and Virus Burden","volume":"7","author":"Chevalier","year":"2016","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/35073648","article-title":"The Dynamics of CD4+ T-Cell Depletion in HIV Disease","volume":"410","author":"McCune","year":"2001","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817bebb3","article-title":"Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases","volume":"48","author":"Baker","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03650.x","article-title":"Factors Influencing the Normalization of CD4+ T-Cell Count, Percentage and CD4+\/CD8+ T-Cell Ratio in HIV-Infected Patients on Long-Term Suppressive Antiretroviral Therapy","volume":"18","author":"Torti","year":"2012","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","article-title":"Incomplete Immune Reconstitution in HIV\/AIDS Patients on Antiretroviral Therapy: Challenges of Immunological non-Responders","volume":"107","author":"Yang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1086\/595851","article-title":"The Absence of CD4+ T Cell Count Recovery Despite Receipt of Virologically Suppressive Highly Active Antiretroviral Therapy: Clinical Risk, Immunological Gaps, and Therapeutic Options","volume":"48","author":"Gazzola","year":"2009","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200001010-00011","article-title":"When Obesity is Desirable: A Longitudinal Study of the Miami HIV-1-Infected Drug Abusers (MIDAS) Cohort","volume":"23","author":"Shor-Posner","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1086\/375889","article-title":"Overweight and Human Immunodeficiency Virus (HIV) Progression in Women: Associations HIV Disease Progression and Changes in Body Mass Index in Women in the HIV Epidemiology Research Study Cohort","volume":"37","author":"Jones","year":"2003","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200103010-00013","article-title":"Prevalence and Predictive Value of Overweight in an Urban HIV Care Clinic","volume":"26","author":"Shuter","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00020-11","article-title":"Impact of Weight on Immune Cell Counts Among HIV-Infected Persons","volume":"18","author":"Crum-Cianflone","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir606","article-title":"An Optimal Body Mass Index Range Associated With Improved Immune Reconstitution Among HIV-Infected Adults Initiating Antiretroviral Therapy","volume":"53","author":"Koethe","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/QAI.0000000000001035","article-title":"Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment","volume":"73","author":"Koethe","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01587","article-title":"Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-48382-5_9","article-title":"The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation","volume":"960","author":"Engin","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2018.08.013","article-title":"CD4(+) T Cells in Obesity and Obesity-Associated Diseases","volume":"332","author":"Zhao","year":"2018","journal-title":"Cell Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0633","article-title":"Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy","volume":"33","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108313","article-title":"T-Cell Activation and Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"210","author":"Nyambuya","year":"2020","journal-title":"Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834e8776","article-title":"Ten-Year Diabetes Incidence in 1046 HIV-Infected Patients Started on a Combination Antiretroviral Treatment","volume":"26","author":"Capeau","year":"2012","journal-title":"AIDS"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort Study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00640","article-title":"Obesity, Fat Mass and Immune System: Role for Leptin","volume":"9","author":"Francisco","year":"2018","journal-title":"Front Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000339201","article-title":"Relationship Between Leptin Levels and Suppressed CD4 Counts in HIV Patients","volume":"22","author":"Al-Fadhli","year":"2013","journal-title":"Med Princ Pract"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11904-021-00541-6","article-title":"Undernutrition and HIV Infection in Sub-Saharan Africa: Health Outcomes and Therapeutic Interventions","volume":"18","author":"Fuseini","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI15693","article-title":"Beneficial Effects of Leptin on Obesity, T Cell Hyporesponsiveness, and Neuroendocrine\/Metabolic Dysfunction of Human Congenital Leptin Deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0376","article-title":"Congenital Leptin Deficiency Due to Homozygosity for the Delta133G Mutation: Report Of Another Case and Evaluation of Response to Four Years of Leptin Therapy","volume":"89","author":"Gibson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1588","article-title":"The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients With Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0597","article-title":"R-Methuleptin Improves Highly Active Antiretroviral Therapy-Induced Lipoatrophy and the Metabolic Syndrome, But Not Through Altering Circulating IGF and IGF-Binding Protein Levels: Observational and Interventional Studies in Humans","volume":"160","author":"Brennan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/J.MOLMED.2015.12.001","article-title":"Leptin Regulation of Immune Responses","volume":"22","author":"Naylor","year":"2016","journal-title":"Trends Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.3390\/ijms21165887","article-title":"Role of Leptin in Inflammation and Vice Versa","volume":"21","author":"P\u00e9rez-P\u00e9rez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622468","article-title":"The Role of the Adipokine Leptin in Immune Cell Function in Health and Disease","volume":"11","author":"Kiernan","year":"2020","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/cimm.1999.1594","article-title":"Human Leptin Enhances Activation and Proliferation of Human Circulating T Lymphocytes","volume":"199","author":"Mart\u00edn-Romero","year":"2000","journal-title":"Cell Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1210\/en.2009-0565","article-title":"Leptin: A Critical Regulator of CD4+ T-Cell Polarization in Vitro and in Vivo","volume":"151","author":"Batra","year":"2010","journal-title":"Endocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.11.6820","article-title":"Leptin Promotes Differentiation and Survival of Human Dendritic Cells and Licenses Them for Th1 Priming","volume":"174","author":"Mattioli","year":"2005","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402996","article-title":"Leptin Receptor Signaling in T Cells is Required for Th17 Differentiation","volume":"194","author":"Reis","year":"2015","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1211606","article-title":"Leptin Up-Regulates TLR2 in Human Monocytes","volume":"93","author":"Jaedicke","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00057.2011","article-title":"Short-Term and Long-Term Leptin Exposure Differentially Affect Human Natural Killer Cell Immune Functions","volume":"302","author":"Wrann","year":"2012","journal-title":"Am J Physiol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01900.x","article-title":"Leptin Receptor (Ob-R) Expression Is Induced in Peripheral Blood Mononuclear Cells by In Vitro Activation and In Vivo in HIV-Infected Patients","volume":"129","author":"S\u00e1nchez-Margalet","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2003.02321.x","article-title":"Leptin Stimulates the Oxidative Burst in Control Monocytes But Attenuates the Oxidative Burst in Monocytes From HIV-Infected Patients","volume":"134","author":"S\u00e1nchez-Pozo","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: More Than a Proliferation Marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"B39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12929-018-0490-9","article-title":"The Effects of Highly Active Antiretroviral Therapy on the Serum Levels of Pro-Inflammatory and Anti-Inflammatory Cytokines in HIV Infected Subjects","volume":"25","author":"Osuji","year":"2018","journal-title":"J BioMed Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32833647a8","article-title":"Th17 Cells and HIV Infection","volume":"5","author":"Elhed","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.10.005","article-title":"IL-17 in Obesity and Adipogenesis","volume":"21","author":"Ahmed","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/QAD.0000000000000893","article-title":"The Metabolic and Cardiovascular Consequences of Obesity in Persons With HIV on Long-Term Antiretroviral Therapy","volume":"30","author":"Koethe","year":"2016","journal-title":"AIDS"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/AID.2016.0113","article-title":"Association of T Cell and Macrophage Activation With Arterial Vascular Health in HIV","volume":"33","author":"Grome","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.36","article-title":"CD4+ T Cells Memorize Obesity and Promote Weight Regain","volume":"15","author":"Zou","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1065","article-title":"Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4